Literature DB >> 8301437

Disseminated measles infection after vaccination in a child with a congenital immunodeficiency.

W J Monafo1, D B Haslam, R L Roberts, S R Zaki, W J Bellini, C M Coffin.   

Abstract

An infant boy with a congenital immunodeficiency had fatal disseminated measles after administration of a live attenuated measles vaccine. This rare complication was confirmed with molecular virologic techniques. Although efforts to expand availability of vaccinations are critically important, caution is warranted in children with potentially severe immunologic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8301437     DOI: 10.1016/s0022-3476(94)70318-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Measles vaccination: Weighing the benefits and risks of a live viral vaccine for HIV-infected children.

Authors: 
Journal:  Can J Infect Dis       Date:  1996-07

Review 2.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 3.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

Review 4.  Vaccination in paediatric rheumatology.

Authors:  Jonathan D Akikusa; Nigel W Crawford
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 5.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 6.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus.

Authors:  Rupak Shivakoti; Debra Hauer; Robert J Adams; Wen-Hsuan W Lin; William Paul Duprex; Rik L de Swart; Diane E Griffin
Journal:  J Interferon Cytokine Res       Date:  2014-12-17       Impact factor: 2.607

8.  Measles vaccine strain from the skin rash of a DiGeorge patient receiving tumor necrosis factor inhibitor.

Authors:  Pui-Ying Iroh Tam; Benjamin R Hanisch; Kate Klammer; Aaron S DeVries
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

9.  Vaccine-acquired rotavirus in infants with severe combined immunodeficiency.

Authors:  Niraj C Patel; Paula M Hertel; Mary K Estes; Maite de la Morena; Ann M Petru; Lenora M Noroski; Paula A Revell; I Celine Hanson; Mary E Paul; Howard M Rosenblatt; Stuart L Abramson
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

10.  Diagnosing inborn error of immunity following the presentation of a complicated acquired infection after MMRV vaccine administration.

Authors:  Lama AlZoebie; Hend Al Sereidi; Shaima Al Maeeni; Musaab Ramsi
Journal:  BMJ Case Rep       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.